Protective Role for Itaconate During Inhaled Allergen Challenge

Area of Science:

• Immunology
• Metabolomics
• Respiratory Medicine

Background:

• Asthma is a chronic respiratory disease involving airway inflammation and remodeling.
• Macrophage function, crucial in asthma, is regulated by cellular metabolism, including the TCA cycle metabolite itaconic acid.
• The role of itaconic acid during inhaled allergen challenge in asthma remains unclear.

Purpose of the Study:

• To investigate the role of itaconate in the context of inhaled allergen challenge in asthma.
• To determine how itaconate levels change following allergen exposure in mild allergic asthma patients and murine models.

Main Methods:

• Measured sputum and bronchoalveolar lavage metabolite levels in human participants and wild-type/aconitase decarboxylase-deficient mice.
• Assessed airway inflammation and lung function in mice.
• Administered inhaled itaconate to house dust mite-exposed mice.

Main Results:

• Sputum itaconate levels significantly decreased after allergen inhalation in mild asthmatics.
• No significant differences in baseline sputum itaconate were observed between healthy controls and asthmatics of varying severity.
• In mice, itaconate deficiency did not alter allergen-induced asthma pathology, but inhaled itaconate treatment reduced airway inflammation.

Conclusions:

• Itaconate levels are dynamically altered following allergen challenge in mild asthmatics and murine models.
• While itaconate deficiency itself did not exacerbate asthma pathology in mice, exogenous itaconate demonstrated anti-inflammatory effects.
• Inhaled itaconate holds potential as a therapeutic agent for ameliorating inflammatory responses in allergic asthma.